Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

By Ahonen M.H.  

Cancer Causes and Control, Vol. 11, Iss. 9, 2000-11 ,pp. : 847-852

Springer Publishing Company

Access to resources Recommend Favorite

Associations of serum 25-hydroxyvitamin D with overall and breast cancer–specific mortality in a multiethnic cohort of breast cancer survivors

By Villaseñor Adriana   Ballard-Barbash Rachel   Ambs Anita   Bernstein Leslie   Baumgartner Kathy   Baumgartner Richard   Ulrich Cornelia   Hollis Bruce   McTiernan Anne   Neuhouser Marian  

Cancer Causes and Control, Vol. 24, Iss. 4, 2013-04 ,pp. : 759-767

Springer Publishing Company

Access to resources Recommend Favorite

Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies

By Wang Dan   Vélez de-la-Paz Omar   Zhai Jun-Xia   Liu Dian-Wu  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3509-3517

Springer Publishing Company

Access to resources Recommend Favorite

Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study

By Bilinski K.  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 599-607

Springer Publishing Company

Access to resources Recommend Favorite

Both serum 25‐hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 925-935

John Wiley & Sons Inc

Access to resources Recommend Favorite